Suppr超能文献

三种天然存在的CC趋化因子对树突状细胞中CCR7的差异性靶向作用

Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-Chemokines.

作者信息

Hjortø Gertrud M, Larsen Olav, Steen Anne, Daugvilaite Viktorija, Berg Christian, Fares Suzan, Hansen Morten, Ali Simi, Rosenkilde Mette M

机构信息

Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, The Panum Institute, University of Copenhagen , Copenhagen , Denmark.

Department of Haematology, Center for Cancer Immune Therapy (CCIT), Copenhagen University Hospital , Herlev , Denmark.

出版信息

Front Immunol. 2016 Dec 9;7:568. doi: 10.3389/fimmu.2016.00568. eCollection 2016.

Abstract

The CCR7 ligands CCL19 and CCL21 are increasingly recognized as functionally different (biased). Using mature human dendritic cells (DCs), we show that CCL19 is more potent than CCL21 in inducing 3D chemotaxis. Intriguingly, CCL21 induces prolonged and more efficient ERK1/2 activation compared with CCL19 and a C-terminal truncated (tailless) CCL21 in DCs. In contrast, tailless-CCL21 displays increased potency in DC chemotaxis compared with native CCL21. Using a CCL21-specific antibody, we show that CCL21, but not tailless-CCL21, accumulates at the cell surface. In addition, removal of sialic acid from the cell surface by neuraminidase treatment impairs ERK1/2 activation by CCL21, but not by CCL19 or tailless-CCL21. Using standard laboratory cell lines, we observe low potency of both CCL21 and tailless-CCL21 in G protein activation and β-arrestin recruitment compared with CCL19, indicating that the tail itself does not improve receptor interaction. Chemokines interact with their receptors in a stepwise manner with ultimate docking of their N-terminus into the main binding pocket. Employing site-directed mutagenesis we identify residues in this pocket of selective CCL21 importance. We also identify a molecular switch in the top of TM7 important for keeping CCR7 in an inactive conformation (Tyr312), as introduction of the chemokine receptor-conserved Glu (or Ala) induces high constitutive activity. Summarized, we show that the interaction of the tail of CCL21 with polysialic acid is needed for strong ERK signaling, whereas it impairs CCL21-mediated chemotaxis and has no impact on receptor docking consistent with the current model of chemokine:receptor interaction. This indicates that future selective pharmacological targeting of CCL19 versus CCL21 should focus on a differential targeting of the main receptor pocket, while selective targeting of tailless-CCL21 versus CCL21 and CCL19 requires targeting of the glycosaminoglycan (GAG) interaction.

摘要

趋化因子受体7(CCR7)的配体CCL19和CCL21在功能上的差异(偏向性)越来越受到认可。利用成熟的人树突状细胞(DC),我们发现CCL19在诱导三维趋化性方面比CCL21更有效。有趣的是,与CCL19和DC中C末端截短(无尾)的CCL21相比,CCL21能诱导更长时间且更有效的细胞外信号调节激酶1/2(ERK1/2)激活。相比之下,无尾CCL21在DC趋化性方面比天然CCL21表现出更高的效力。使用CCL21特异性抗体,我们发现CCL21而非无尾CCL21在细胞表面积累。此外,用神经氨酸酶处理去除细胞表面的唾液酸会削弱CCL21介导的ERK1/2激活,但不影响CCL19或无尾CCL21介导的激活。使用标准实验室细胞系,我们观察到与CCL19相比,CCL21和无尾CCL21在G蛋白激活和β - 抑制蛋白募集方面效力较低,这表明尾巴本身并不能改善受体相互作用。趋化因子以逐步方式与其受体相互作用,最终其N末端对接至主要结合口袋。通过定点诱变,我们确定了CCL21选择性重要的该口袋中的残基。我们还在跨膜结构域7(TM7)顶部确定了一个分子开关,它对于使CCR7保持无活性构象很重要(酪氨酸312),因为引入趋化因子受体保守的谷氨酸(或丙氨酸)会诱导高组成性活性。总之,我们表明CCL21的尾巴与多唾液酸的相互作用是强烈ERK信号传导所必需的,而它会损害CCL21介导的趋化性,并且与当前趋化因子:受体相互作用模型一致,对受体对接没有影响。这表明未来针对CCL19与CCL21的选择性药理学靶向应侧重于对主要受体口袋的差异靶向,而针对无尾CCL21与CCL21和CCL19的选择性靶向则需要靶向糖胺聚糖(GAG)相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5594/5145889/bda101134afe/fimmu-07-00568-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验